CHCO Q1 2026 Earnings Slight EPS Beat Amid Stable Operations GALT Q1 2026 Earnings EPS Misses Estimates as Clinical Development Continues MAR Q1 2026 Earnings Strong EPS Beat Amid Market Skepticism Kilroy Realty Q1 2026 Earnings Significant EPS Miss as Office Market Challenges Persist Tenaya Therapeutics Q1 2026 Earnings Narrow Miss on Earnings as Biotech Firm Reports No Revenue HMR Q1 2026 Earnings EPS Beats Estimates by Over 1000 but Stock Tumbles 20